CONTINUE TO SITE
OR WAIT null SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Generics Debate Escalates
February 1, 2001
Jill Wechsler, Pharm Exec's Washington Correspondent
Jill Wechsler, Pharm Exec's Washington Correspondent
Jill Wechsler is Pharm Exec's Washington Corespondent
Pharmaceutical Executive
Pharmaceutical Executive, Pharmaceutical Executive-12-01-2001, Volume 0, Issue 0
Calls for change reflect that generic products are a therapeutic mainstay and that patients and providers want earlier access to inexpensive medicines.
Related Content:
